These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 39334820)
1. BMP2 Diminishes Angiotensin II-Induced Atrial Fibrillation by Inhibiting NLRP3 Inflammasome Signaling in Atrial Fibroblasts. Yuan Y; Zhang H; Xia E; Zhao X; Gao Q; Mu H; Liu X; Tian Y; Liu L; Shen Q; Sheng L Biomolecules; 2024 Aug; 14(9):. PubMed ID: 39334820 [TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias. Scott L; Fender AC; Saljic A; Li L; Chen X; Wang X; Linz D; Lang J; Hohl M; Twomey D; Pham TT; Diaz-Lankenau R; Chelu MG; Kamler M; Entman ML; Taffet GE; Sanders P; Dobrev D; Li N Cardiovasc Res; 2021 Jun; 117(7):1746-1759. PubMed ID: 33523143 [TBL] [Abstract][Full Text] [Related]
3. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway. Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin I Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214 [TBL] [Abstract][Full Text] [Related]
5. Role of NLRP3-Inflammasome/Caspase-1/Galectin-3 Pathway on Atrial Remodeling in Diabetic Rabbits. Wu X; Liu Y; Tu D; Liu X; Niu S; Suo Y; Liu T; Li G; Liu C J Cardiovasc Transl Res; 2020 Oct; 13(5):731-740. PubMed ID: 32048199 [TBL] [Abstract][Full Text] [Related]
6. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830 [TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation. Song J; Navarro-Garcia JA; Wu J; Saljic A; Abu-Taha I; Li L; Lahiri SK; Keefe JA; Aguilar-Sanchez Y; Moore OM; Yuan Y; Wang X; Kamler M; Mitch WE; Ruiz-Hurtado G; Hu Z; Thomas SS; Dobrev D; Wehrens XH; Li N J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37581942 [TBL] [Abstract][Full Text] [Related]
8. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Yao C; Veleva T; Scott L; Cao S; Li L; Chen G; Jeyabal P; Pan X; Alsina KM; Abu-Taha I; Ghezelbash S; Reynolds CL; Shen YH; LeMaire SA; Schmitz W; Müller FU; El-Armouche A; Tony Eissa N; Beeton C; Nattel S; Wehrens XHT; Dobrev D; Li N Circulation; 2018 Nov; 138(20):2227-2242. PubMed ID: 29802206 [TBL] [Abstract][Full Text] [Related]
9. Silencing of TLR4 Inhibits Atrial Fibrosis and Susceptibility to Atrial Fibrillation via Downregulation of NLRP3-TGF- Ge C; Zhao Y; Liang Y; He Y Dis Markers; 2022; 2022():2466150. PubMed ID: 35860690 [TBL] [Abstract][Full Text] [Related]
10. Mir-21 Mediates the Inhibitory Effect of Ang (1-7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts. Sun NN; Yu CH; Pan MX; Zhang Y; Zheng BJ; Yang QJ; Zheng ZM; Meng Y Sci Rep; 2017 Oct; 7(1):14369. PubMed ID: 29084974 [TBL] [Abstract][Full Text] [Related]
11. Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling. Zhan G; Wang X; Wang X; Li J; Tang Y; Bi H; Yang X; Xia Y Eur J Pharmacol; 2024 Sep; 978():176712. PubMed ID: 38906237 [TBL] [Abstract][Full Text] [Related]
12. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Fukui A; Takahashi N; Nakada C; Masaki T; Kume O; Shinohara T; Teshima Y; Hara M; Saikawa T Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):402-9. PubMed ID: 23406575 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II Triggers NLRP3 Inflammasome Activation by a Ca Espitia-Corredor JA; Boza P; Espinoza-Pérez C; Lillo JM; Rimassa-Taré C; Machuca V; Osorio-Sandoval JM; Vivar R; Bolivar S; Pardo-Jiménez V; Sánchez-Ferrer CF; Peiró C; Díaz-Araya G Inflammation; 2022 Dec; 45(6):2498-2512. PubMed ID: 35867264 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of fibromodulin attenuates inflammatory signaling and atrial fibrosis in spontaneously hypertensive rats with atrial fibrillation via inhibiting TLR4/NLRP3 signaling pathway. Liang Y; Zhou Y; Wang J; He Y Immun Inflamm Dis; 2023 Oct; 11(10):e1003. PubMed ID: 37904680 [TBL] [Abstract][Full Text] [Related]
15. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice. Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551 [TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms. Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367 [TBL] [Abstract][Full Text] [Related]
17. SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/smad2/3 signalling pathway. Hu HJ; Wang XH; Zhang ZZ; Ou Y; Ning ZH; Yang JY; Huang H; Tang HF; Jiang ZS Eur J Pharmacol; 2024 Nov; 982():176900. PubMed ID: 39168432 [TBL] [Abstract][Full Text] [Related]
18. IL-1β Plays an Important Role in Pressure Overload-Induced Atrial Fibrillation in Mice. Matsushita N; Ishida N; Ibi M; Saito M; Takahashi M; Taniguchi S; Iwakura Y; Morino Y; Taira E; Sawa Y; Hirose M Biol Pharm Bull; 2019; 42(4):543-546. PubMed ID: 30930414 [TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis of Indeterminate Potential With Loss of Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791 [TBL] [Abstract][Full Text] [Related]
20. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation. Gan W; Ren J; Li T; Lv S; Li C; Liu Z; Yang M Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):1-10. PubMed ID: 28986310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]